138 related articles for article (PubMed ID: 32676363)
1. Three-dimensional fast single-point macromolecular proton fraction mapping of the human brain at 0.5 Tesla.
Anisimov NV; Pavlova OS; Pirogov YA; Yarnykh VL
Quant Imaging Med Surg; 2020 Jul; 10(7):1441-1449. PubMed ID: 32676363
[TBL] [Abstract][Full Text] [Related]
2. High-resolution three-dimensional macromolecular proton fraction mapping for quantitative neuroanatomical imaging of the rodent brain in ultra-high magnetic fields.
Naumova AV; Akulov AE; Khodanovich MY; Yarnykh VL
Neuroimage; 2017 Feb; 147():985-993. PubMed ID: 27646128
[TBL] [Abstract][Full Text] [Related]
3. Scan-Rescan Repeatability and Impact of B
Yarnykh VL; Kisel AA; Khodanovich MY
J Magn Reson Imaging; 2020 Jun; 51(6):1789-1798. PubMed ID: 31737961
[TBL] [Abstract][Full Text] [Related]
4. Time-efficient, high-resolution, whole brain three-dimensional macromolecular proton fraction mapping.
Yarnykh VL
Magn Reson Med; 2016 May; 75(5):2100-6. PubMed ID: 26102097
[TBL] [Abstract][Full Text] [Related]
5. Fast whole-brain three-dimensional macromolecular proton fraction mapping in multiple sclerosis.
Yarnykh VL; Bowen JD; Samsonov A; Repovic P; Mayadev A; Qian P; Gangadharan B; Keogh BP; Maravilla KR; Jung Henson LK
Radiology; 2015 Jan; 274(1):210-20. PubMed ID: 25208343
[TBL] [Abstract][Full Text] [Related]
6. Direct comparison between apparent diffusion coefficient and macromolecular proton fraction as quantitative biomarkers of the human fetal brain maturation.
Korostyshevskaya AM; Prihod'ko IY; Savelov AA; Yarnykh VL
J Magn Reson Imaging; 2019 Jul; 50(1):52-61. PubMed ID: 30635965
[TBL] [Abstract][Full Text] [Related]
7. Fast macromolecular proton fraction mapping of the human liver in vivo for quantitative assessment of hepatic fibrosis.
Yarnykh VL; Tartaglione EV; Ioannou GN
NMR Biomed; 2015 Dec; 28(12):1716-25. PubMed ID: 26503401
[TBL] [Abstract][Full Text] [Related]
8. High-resolution three-dimensional quantitative map of the macromolecular proton fraction distribution in the normal rat brain.
Naumova AV; Akulov AE; Khodanovich MY; Yarnykh VL
Data Brief; 2017 Feb; 10():381-384. PubMed ID: 28018953
[TBL] [Abstract][Full Text] [Related]
9. Determination of optimal parameters for 3D single-point macromolecular proton fraction mapping at 7T in healthy and demyelinated mouse brain.
Soustelle L; Antal MC; Lamy J; Harsan LA; Loureiro de Sousa P
Magn Reson Med; 2021 Jan; 85(1):369-379. PubMed ID: 32767495
[TBL] [Abstract][Full Text] [Related]
10. Data-Driven Retrospective Correction of B
Yarnykh VL
IEEE Trans Med Imaging; 2021 Dec; 40(12):3473-3484. PubMed ID: 34110989
[TBL] [Abstract][Full Text] [Related]
11. Macromolecular Proton Fraction as a Myelin Biomarker: Principles, Validation, and Applications.
Kisel AA; Naumova AV; Yarnykh VL
Front Neurosci; 2022; 16():819912. PubMed ID: 35221905
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Imaging of White and Gray Matter Remyelination in the Cuprizone Demyelination Model Using the Macromolecular Proton Fraction.
Khodanovich M; Pishchelko A; Glazacheva V; Pan E; Akulov A; Svetlik M; Tyumentseva Y; Anan'ina T; Yarnykh V
Cells; 2019 Oct; 8(10):. PubMed ID: 31590363
[TBL] [Abstract][Full Text] [Related]
13. Developmental and regional dependence of macromolecular proton fraction and fractional anisotropy in fixed brain tissue.
Drobyshevsky A; Synowiec S; Goussakov I; Yarnykh V
NMR Biomed; 2023 Jul; 36(7):e4915. PubMed ID: 36895100
[TBL] [Abstract][Full Text] [Related]
14. Global hypomyelination of the brain white and gray matter in schizophrenia: quantitative imaging using macromolecular proton fraction.
Smirnova LP; Yarnykh VL; Parshukova DA; Kornetova EG; Semke AV; Usova AV; Pishchelko AO; Khodanovich MY; Ivanova SA
Transl Psychiatry; 2021 Jun; 11(1):365. PubMed ID: 34226491
[TBL] [Abstract][Full Text] [Related]
15. STrategically Acquired Gradient Echo (STAGE) imaging, part I: Creating enhanced T1 contrast and standardized susceptibility weighted imaging and quantitative susceptibility mapping.
Chen Y; Liu S; Wang Y; Kang Y; Haacke EM
Magn Reson Imaging; 2018 Feb; 46():130-139. PubMed ID: 29056394
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Assessment of Normal Fetal Brain Myelination Using Fast Macromolecular Proton Fraction Mapping.
Yarnykh VL; Prihod'ko IY; Savelov AA; Korostyshevskaya AM
AJNR Am J Neuroradiol; 2018 Jul; 39(7):1341-1348. PubMed ID: 29748201
[TBL] [Abstract][Full Text] [Related]
17. Iron-Insensitive Quantitative Assessment of Subcortical Gray Matter Demyelination in Multiple Sclerosis Using the Macromolecular Proton Fraction.
Yarnykh VL; Krutenkova EP; Aitmagambetova G; Repovic P; Mayadev A; Qian P; Jung Henson LK; Gangadharan B; Bowen JD
AJNR Am J Neuroradiol; 2018 Apr; 39(4):618-625. PubMed ID: 29439122
[TBL] [Abstract][Full Text] [Related]
18. Detecting Early-Stage Liver Fibrosis Using Macromolecular Proton Fraction Mapping Based on Spin-Lock MRI: Preliminary Observations.
Hou J; Wong VW; Qian Y; Jiang B; Chan AW; Leung HH; Wong GL; Yu SC; Chu WC; Chen W
J Magn Reson Imaging; 2023 Feb; 57(2):485-492. PubMed ID: 35753084
[TBL] [Abstract][Full Text] [Related]
19. Age-Related Decline in Brain Myelination: Quantitative Macromolecular Proton Fraction Mapping, T2-FLAIR Hyperintensity Volume, and Anti-Myelin Antibodies Seven Years Apart.
Khodanovich M; Svetlik M; Naumova A; Kamaeva D; Usova A; Kudabaeva M; Anan'ina T; Wasserlauf I; Pashkevich V; Moshkina M; Obukhovskaya V; Kataeva N; Levina A; Tumentceva Y; Yarnykh V
Biomedicines; 2023 Dec; 12(1):. PubMed ID: 38255168
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of demyelination in ischemic stroke in vivo using macromolecular proton fraction mapping.
Khodanovich MY; Kisel AA; Akulov AE; Atochin DN; Kudabaeva MS; Glazacheva VY; Svetlik MV; Medvednikova YA; Mustafina LR; Yarnykh VL
J Cereb Blood Flow Metab; 2018 May; 38(5):919-931. PubMed ID: 29372644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
